Tumor-associated proteolysis and prognosis: New functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system
Heiss MM, Babic R, Allgayer H, et al. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J Clin Oncol 1995;13:2084-2093.
Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma
Maeda K, Chung YS, Takatsuka S, et al. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72:319-323.
Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo
Yamamoto M, Sawaya R, Mohanam S, et al. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 1994;54:3656-3661.
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 anti-sense oligonucleotides
Chen ZQ, Fisher RJ, Riggs CW, et al. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 anti-sense oligonucleotides. Cancer Res 1997;57:2013-2019.
In vitro inhibition of human malignant brain tumor cell line proliferation by and-urokinase-type plasminogen activator monoclonal antibodies
Abaza MS, Shaban FA, Narayan RK, et al. In vitro inhibition of human malignant brain tumor cell line proliferation by and-urokinase-type plasminogen activator monoclonal antibodies. Br J Cancer 1998;78:1578-1585.
Adenovirus-mediated delivery of anti-sense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth
Mohan PM, Chintala SK, Mohanam S, et al. Adenovirus-mediated delivery of anti-sense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Cancer Res 1999;59:3369-3373.